問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Division of Thoracic Medicine
Division of Radiology
更新時間:2023-09-19
Recruiting Trial
7Cases
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
黃威銘
下載
2023-03-27 - 2029-07-30
Condition/Disease
Test Drug
Participate Sites6Sites
Not yet recruiting5Sites
Recruiting1Sites
2020-04-01 - 2025-11-26
Previously Untreated, Locally Advanced Non-small Cell Lung Cancer
OPDIVO (nivolumab) Injection 10mg/mL OPDIVO (nivolumab) Injection 10mg/mL YERVOY (ipilimumab) Injection 5mg/mL YERVOY (ipilimumab) Injection 5mg/mL
Participate Sites7Sites
Not yet recruiting1Sites
Recruiting6Sites
全部